|
TUBD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.688150E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.523800E-02 |
| Normal-vs-Stage2 |
3.445000E-01 |
| Normal-vs-Stage3 |
5.537800E-01 |
| Normal-vs-Stage4 |
3.573200E-01 |
| Stage1-vs-Stage2 |
9.359800E-01 |
| Stage1-vs-Stage3 |
4.917600E-01 |
| Stage1-vs-Stage4 |
9.123400E-01 |
| Stage2-vs-Stage3 |
6.737800E-01 |
| Stage2-vs-Stage4 |
8.895600E-01 |
| Stage3-vs-Stage4 |
6.086000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.702030E-02 |
| Normal-vs-AfricanAmerican |
1.401200E-01 |
| Normal-vs-Asian |
1.359370E-01 |
| Caucasian-vs-AfricanAmerican |
5.505600E-01 |
| Caucasian-vs-Asian |
8.066600E-01 |
| AfricanAmerican-vs-Asian |
6.082600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.134100E-02 |
| Normal-vs-Female |
3.854100E-02 |
| Male-vs-Female |
5.816200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.649800E-01 |
| Normal-vs-Extreme_Weight |
2.963900E-02 |
| Normal-vs-Obese |
7.356400E-02 |
| Normal-vs-Extreme_Obese |
6.110800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.113000E-01 |
| Normal_Weight-vs-Obese |
3.458800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.581800E-01 |
| Extreme_Weight-vs-Obese |
6.544000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.882600E-01 |
| Obese-vs-Extreme_Obese |
5.598000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.724420E-02 |
| Normal-vs-Age(41-60Yrs) |
3.775900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.662800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.050800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.020200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.133000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.725500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.281800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.964300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.320200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.7513000000049E-05 |
| Normal-VS-Type2 PRCC |
2.409000E-01 |
| Normal-VS-KIRP CIMP |
8.889600E-01 |
| Normal-VS-Unclassified PRCC |
4.082600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.71319999964226E-07 |
| Type1 PRCC-VS-KIRP CIMP |
2.958400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.265800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.238200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.964200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.888600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.126400E-01 |
| Normal-vs-N1 |
1.597230E-01 |
| Normal-vs-N2 |
3.500400E-01 |
| N0-vs-N1 |
2.767000E-01 |
| N0-vs-N2 |
6.972000E-01 |
| N1-vs-N2 |
8.064000E-01 |
|
|
